Table 2.
BACC from 10-fold cross-validation performed two times on the 24 datasets depicted along with the overall averages (AVG) and their SD
| # | Conj_ RL | Ripper | C4.5 | BRL1 | BRL1000 |
|---|---|---|---|---|---|
| 1 | 98.34 | 98.65 | 100.00 | 100.00 | 100.00 |
| 2 | 29.83 | 44.20 | 66.91 | 86.22 | 100.00 |
| 3 | 47.29 | 54.39 | 60.41 | 50.71 | 54.88 |
| 4 | 47.46 | 43.92 | 43.47 | 59.29 | 69.15 |
| 5 | 30.24 | 32.45 | 37.68 | 41.17 | 47.17 |
| 6 | 87.42 | 81.83 | 84.50 | 83.75 | 82.75 |
| 7 | 81.70 | 81.70 | 81.70 | 97.50 | 100.00 |
| 8 | 20.70 | 25.54 | 38.56 | 45.00 | 63.75 |
| 9 | 41.89 | 47.36 | 42.56 | 61.41 | 74.71 |
| 10 | 37.19 | 59.83 | 58.96 | 59.92 | 61.24 |
| 11 | 26.04 | 29.62 | 38.81 | 45.62 | 48.90 |
| 12 | 51.76 | 53.40 | 55.53 | 57.08 | 47.50 |
| 13 | 51.73 | 62.48 | 70.28 | 65.00 | 68.46 |
| 14 | 40.81 | 44.81 | 42.93 | 43.31 | 49.63 |
| 15 | 43.55 | 46.64 | 46.39 | 54.56 | 57.78 |
| 16 | 47.13 | 59.48 | 71.69 | 80.50 | 83.17 |
| 17 | 40.93 | 47.59 | 40.73 | 82.17 | 74.67 |
| 18 | 23.91 | 29.88 | 33.80 | 26.95 | 55.78 |
| 19 | 40.52 | 55.57 | 48.71 | 76.83 | 77.50 |
| 20 | 50.22 | 71.30 | 83.81 | 60.00 | 73.75 |
| 21 | 40.98 | 43.09 | 42.52 | 49.29 | 51.27 |
| 22 | 53.54 | 48.19 | 54.92 | 61.59 | 65.07 |
| 23 | 44.60 | 57.38 | 50.05 | 64.34 | 53.20 |
| 24 | 61.99 | 50.79 | 64.47 | 75.83 | 63.33 |
| AVG | 47.57 | 52.80 | 56.64 | 63.66 | 67.65 |
| (SD) | (19.03) | (17.44) | (17.91) | (18.45) | (16.57) |
| GA | 46.74 | 52.89 | 56.66 | 63.16 | 68.67 |
| (SD) | (20.08) | (18.64) | (19.06) | (19.58) | (17.39) |
| PA | 53.38 | 52.12 | 56.48 | 67.25 | 60.53 |
| (SD) | (8.70) | (4.74) | (7.34) | (7.55) | (6.41) |
Averages over the genomic datasets 1–21 (GA) and their SDs, as well as averages over the proteomic datasets 22–24 (PA) and their SDs. Bold numbers indicate highest performance on a dataset.